Researchers at the Department of Dermatology at Inselspital have discovered a relationship between cells which could advance the treatment of allergic skin diseases. Their discovery was published in Science Immunology.
The function of so-called “TH9” cells in humans remains elusive. These interleukin-9 (IL-9)-producing T helper (TH) cells play an important role in inflammatory reactions and tumor immunity in animal models.
In order to better understand the role of TH9 cells in humans, Prof. Dr. Christoph Schlapbach and his research team at the Department of Dermatology at Inselspital and the Department for Biomedical Research at the University of Bern have examined these cells in greater depth.
Closely related allergy-inducing T cells
Most notably, the team discovered that TH9 cells are not a separate population, but rather a distinct subpopulation of the already known TH2 cells which contribute decisively to the induction of allergies. As a result, they were characterised as “IL-9+ TH2 cells”.
Consistent with this interrelation, the researchers have found that this cell type is involved in such allergic skin diseases as atopic dermatitis (atopic eczema, neurodermatitis) or allergic contact eczema.
In order to understand how the new cells can be distinguished from conventional TH2 cells, the team carried out modern transcriptomic analyses. In the course of this, the transcription factor PPAR-γ was identified as an important regulator of IL-9+ TH2 cells.
PPAR-γ is a well-known regulator of cellular metabolism, i.e. the processes occurring in cells to produce energy and biologic building blocks. Until now, the function of PPAR-γ in fat and muscle cells was known, but its function in TH cells has only recently been examined.
An old acquaintance and new therapeutic approaches
PPAR-γ has already been used as a therapeutic target for treating type 2 diabetes. The fact that it also plays a key role in IL-9+ TH2 cells therefore opens up new ways for treating such allergic skin diseases as neurodermatitis.
“Because PPAR-y regulates the cells that have now been characterised, we might be able to manipulate this cell population with it,” explains Christoph Schlapbach.
“It is therefore conceivable that already existing medications can be used to treat diseases in which IL-9+ TH cells are involved, a process called "drug repositioning”."
Before this hypothesis can be tested in initial clinical trials, the researchers now want to examine more closely how IL-9 and PPAR-y interact in allergic skin conditions. For this purpose, continuation studies are currently being carried out at the Department of Dermatology at Inselspital.
Prof. Dr. med. Christoph Schlapbach, Senior Physician, Prof. Dr. med. Christoph Schlapbach, Senior Physician, Department of Dermatology, Inselspital, Bern University Hospital, and Department of BioMedical Research, University of Bern, Christoph.Schlapbach@insel.ch.
Monika Kugemann | idw - Informationsdienst Wissenschaft
Turning carbon dioxide into liquid fuel
06.08.2020 | DOE/Argonne National Laboratory
Tellurium makes the difference
06.08.2020 | Friedrich-Schiller-Universität Jena
Scientists at the Fraunhofer Institute for Laser Technology ILT have come up with a striking new addition to contact stamping technologies in the ERDF research project ScanCut. In collaboration with industry partners from North Rhine-Westphalia, the Aachen-based team of researchers developed a hybrid manufacturing process for the laser cutting of thin-walled metal strips. This new process makes it possible to fabricate even the tiniest details of contact parts in an eco-friendly, high-precision and efficient manner.
Plug connectors are tiny and, at first glance, unremarkable – yet modern vehicles would be unable to function without them. Several thousand plug connectors...
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.
Osteoporosis is the most common age-related bone disease which affects hundreds of millions of individuals worldwide. It is estimated that one in three women...
Traditional single-cell sequencing methods help to reveal insights about cellular differences and functions - but they do this with static snapshots only...
“Core-shell” clusters pave the way for new efficient nanomaterials that make catalysts, magnetic and laser sensors or measuring devices for detecting electromagnetic radiation more efficient.
Whether in innovative high-tech materials, more powerful computer chips, pharmaceuticals or in the field of renewable energies, nanoparticles – smallest...
An international research team with Prof. Cornelia Denz from the Institute of Applied Physics at the University of Münster develop for the first time light fields using caustics that do not change during propagation. With the new method, the physicists cleverly exploit light structures that can be seen in rainbows or when light is transmitted through drinking glasses.
Modern applications as high resolution microsopy or micro- or nanoscale material processing require customized laser beams that do not change during...
23.07.2020 | Event News
21.07.2020 | Event News
07.07.2020 | Event News
06.08.2020 | Earth Sciences
06.08.2020 | Power and Electrical Engineering
06.08.2020 | Life Sciences